Pfizer says that more interim results from its ongoing coronavirus vaccine study suggest the shots are 95 per cent effective and that the vaccine protects older people most at risk of dying from COVID-19.
Pfizer says that more interim results from its ongoing coronavirus vaccine study suggest the shots are 95 per cent effective and that the vaccine protects older people most at risk of dying from COVID-19.